NASDAQ : CBLL
CeriBell, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 27.82 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.07B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
CeriBell, Inc. (CBLL) reported revenue of 101.96M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | 101.96M | 89.06M | 65.44M | 45.23M | 25.92M |
| Cost of Revenue | 11.32M | 10.79M | 8.69M | 7.06M | 4.43M |
| Gross Profit | 90.64M | 78.27M | 56.75M | 38.16M | 21.49M |
| Selling, General & Admin | 137.66M | 117.53M | 82.90M | 59.21M | 50.27M |
| Research & Development | 22.95M | 19.14M | 13.56M | 8.99M | 7.24M |
| Operating Expenses | 160.61M | 136.68M | 96.46M | 68.20M | 57.51M |
| Operating Income | -69.97M | -58.40M | -39.71M | -30.04M | -36.02M |
| Interest Expense | -1.81M | -1.89M | -1.99M | -2.10M | -1.60M |
| Other Non Operating Income (Expenses) | 5.79M | 6.88M | 1.25M | 2.69M | 462.00K |
| Pretax Income | -66.00M | -53.41M | -40.45M | -29.45M | -37.16M |
| Income Tax Expense | 11.00K | 2.00K | |||
| Net Income | -66.00M | -53.41M | -40.45M | -29.46M | -37.16M |
| Net Income to Common | -66.00M | -53.41M | -40.45M | -29.46M | -37.16M |
| Shares Outstanding (Basic) | 37.42M | 36.54M | 11.95M | 5.30M | 5.10M |
| Shares Outstanding (Diluted) | 37.42M | 36.54M | 11.95M | 5.30M | 5.10M |
| EPS (Basic) | -1.76 | -1.46 | -3.39 | -5.56 | -7.29 |
| EPS (Diluted) | -1.76 | -1.46 | -3.39 | -5.56 | -7.29 |
| Free Cash Flow | -56.10M | -42.33M | -36.64M | -30.92M | -33.40M |
| Free Cash Flow Per Share | -1.50 | -1.16 | -3.07 | -5.83 | -6.55 |
| Gross Margin | 88.90% | 87.89% | 86.72% | 84.39% | 82.91% |
| Operating Margin | -68.62% | -65.57% | -60.68% | -66.43% | -138.96% |
| Profit Margin | -64.73% | -59.97% | -61.82% | -65.15% | -143.37% |
| Free Cash Flow Margin | -55.02% | -47.53% | -55.99% | -68.37% | -128.85% |
| EBITDA | -68.80M | -57.06M | -38.57M | -29.19M | -35.52M |
| EBITDA Margin | -67.48% | -64.07% | -58.93% | -64.55% | -137.04% |
| D&A For EBITDA | 1.17M | 1.34M | 1.14M | 847.00K | 497.00K |
| EBIT | -69.97M | -58.40M | -39.71M | -30.04M | -36.02M |
| EBIT Margin | -68.62% | -65.57% | -60.68% | -66.43% | -138.96% |
| Revenue as Reported | 101.96M | 89.06M | 65.44M | 45.23M | 25.92M |
| Advertising Expenses | 200.00K | 400.00K | 500.00K | 282.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 32.66M | 40.48M | 194.37M | 34.49M | 68.23M |
| Short-Term Investments | 96.60M | 118.78M | |||
| Cash & Short-Term Investments | 129.26M | 159.26M | 194.37M | 34.49M | 68.23M |
| Receivables | 15.99M | 15.05M | 10.88M | 7.96M | 5.29M |
| Inventory | 6.74M | 7.29M | 6.94M | 5.87M | 4.08M |
| Prepaid Expenses | 3.66M | 2.91M | 3.25M | 2.13M | 1.17M |
| Other Current Assets | 2.20M | 2.21M | 1.84M | 1.51M | 1.03M |
| Total Current Assets | 157.85M | 186.72M | 217.27M | 51.96M | 79.80M |
| Property, Plant & Equipment | 6.18M | 6.27M | 6.07M | 5.57M | 5.44M |
| Long-Term Deferred Charges | 1.70M | 2.18M | 1.85M | 1.24M | 952.00K |
| Other Long-Term Assets | 621.00K | 631.00K | 217.00K | 152.00K | 266.00K |
| Total Assets | 166.35M | 195.80M | 225.41M | 58.92M | 86.46M |
| Accounts Payable | 3.19M | 2.84M | 1.14M | 732.00K | 423.00K |
| Accrued Expenses | 12.48M | 14.33M | 10.05M | 7.54M | 5.82M |
| Current Portion of Long-Term Debt | 11.83M | 2.50M | |||
| Current Portion of Leases | 1.18M | 1.10M | 1.09M | 694.00K | 629.00K |
| Current Unearned Revenue | 11.00K | 101.00K | 97.00K | 206.00K | 343.00K |
| Other Current Liabilities | 343.00K | 818.00K | 609.00K | 595.00K | 146.00K |
| Total Current Liabilities | 17.20M | 19.19M | 12.99M | 21.60M | 9.86M |
| Long-Term Debt | 19.98M | 19.81M | 19.56M | 12.72M | |
| Long-Term Leases | 748.00K | 1.36M | 1.31M | 1.68M | 2.37M |
| Long-Term Unearned Revenue | 30.00K | 44.00K | |||
| Other Long-Term Liabilities | 106.00K | 106.00K | 356.00K | 441.00K | 489.00K |
| Total Liabilities | 38.03M | 40.47M | 34.25M | 23.76M | 25.44M |
| Common Stock | 39.00K | 38.00K | 36.00K | 5.00K | 5.00K |
| Additional Paid-In Capital | 387.73M | 375.50M | 358.07M | 14.23M | 10.62M |
| Retained Earnings | -259.36M | -220.36M | -166.94M | -126.49M | -97.03M |
| Comprehensive Income & Other | -92.00K | 159.00K | |||
| Total Common Equity | 128.31M | 155.34M | 191.16M | -112.25M | -86.40M |
| Shareholders' Equity | 128.31M | 155.34M | 191.16M | 35.16M | 61.01M |
| Total Liabilities & Equity | 166.35M | 195.80M | 225.41M | 58.92M | 86.46M |
| Total Debt | 21.91M | 22.28M | 21.96M | 14.20M | 18.22M |
| Net Cash (Debt) | 107.35M | 136.99M | 172.41M | 20.29M | 50.02M |
| Net Cash Per Share | 2.87 | 3.75 | 14.43 | 3.83 | 9.81 |
| Filing Date Shares Outstanding | 38.38M | 37.64M | 35.87M | 5.59M | 5.12M |
| Total Common Shares Outstanding | 38.22M | 37.49M | 35.85M | 5.43M | 5.12M |
| Working Capital | 140.65M | 167.53M | 204.28M | 30.36M | 69.94M |
| Book Value Per Share | 3.36 | 4.14 | 5.33 | -20.67 | -16.86 |
| Tangible Book Value | 128.31M | 155.34M | 191.16M | -112.25M | -86.40M |
| Tangible Book Value Per Share | 3.36 | 4.14 | 5.33 | -20.67 | -16.86 |
| Machinery | 7.56M | 6.64M | 5.06M | 4.53M | 3.28M |
| Construction In Progress | 147.00K | 218.00K | 586.00K | 387.00K | 100.00K |
| Leasehold Improvements | 855.00K | 852.00K | 810.00K | 348.00K | 342.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Net Income | -66.00M | -53.41M | -40.45M | -29.46M | -37.16M |
| Depreciation & Amortization | 1.17M | 1.34M | 1.14M | 847.00K | 497.00K |
| Other Amortization | 363.00K | 415.00K | 382.00K | 363.00K | 280.00K |
| Loss (Gain) From Sale of Assets | 116.00K | 104.00K | 95.00K | 181.00K | 98.00K |
| Loss (Gain) From Sale of Investments | -2.77M | -2.01M | |||
| Stock-Based Compensation | 16.43M | 12.22M | 5.41M | 2.68M | 7.93M |
| Other Operating Activities | -74.00K | -101.00K | 1.55M | -67.00K | 243.00K |
| Change in Accounts Receivable | -3.68M | -4.17M | -2.92M | -2.66M | -3.06M |
| Change in Inventory | -738.00K | -351.00K | -1.07M | -1.79M | -1.90M |
| Change in Accounts Payable | 790.00K | 1.75M | 250.00K | 309.00K | 124.00K |
| Change in Unearned Revenue | -212.00K | -26.00K | -123.00K | -93.00K | 95.00K |
| Change in Other Net Operating Assets | 583.00K | 3.44M | 692.00K | 541.00K | 862.00K |
| Operating Cash Flow | -54.03M | -40.81M | -35.04M | -29.16M | -32.00M |
| Capital Expenditures | -2.06M | -1.52M | -1.60M | -1.76M | -1.40M |
| Investment in Securities | 43.06M | -116.61M | |||
| Investing Cash Flow | 41.00M | -118.14M | -1.60M | -1.76M | -1.40M |
| Long-Term Debt Issued | 7.91M | ||||
| Long-Term Debt Repaid | -3.75M | -39.00K | |||
| Net Debt Issued (Repaid) | 7.91M | -3.75M | -39.00K | ||
| Issuance of Common Stock | 5.79M | 5.44M | 193.96M | 932.00K | 154.00K |
| Repurchase of Common Stock | -236.00K | -236.00K | |||
| Other Financing Activities | -150.00K | -5.35M | -310.00K | ||
| Financing Cash Flow | 5.55M | 5.05M | 196.52M | -2.82M | 49.80M |
| Net Cash Flow | -7.48M | -153.89M | 159.88M | -33.74M | 16.40M |
| Free Cash Flow | -56.10M | -42.33M | -36.64M | -30.92M | -33.40M |
| Free Cash Flow Margin | -55.02% | -47.53% | -55.99% | -68.37% | -128.85% |
| Free Cash Flow Per Share | -1.50 | -1.16 | -3.07 | -5.83 | -6.55 |
| Levered Free Cash Flow | -33.05M | -23.60M | -23.33M | -21.53M | |
| Unlevered Free Cash Flow | -32.28M | -22.83M | -22.47M | -20.58M | |
| Cash Interest Paid | 1.82M | 1.89M | 1.95M | 1.73M | 1.63M |
| Change in Working Capital | -3.26M | 633.00K | -3.17M | -3.70M | -3.88M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Market Capitalization | 1.03B | 813.51M | 927.13M | ||
| Enterprise Value | 927.32M | 666.31M | 1.08B | ||
| Last Close Price | 26.96 | 21.93 | 25.88 | ||
| PS Ratio | 10.15 | 9.13 | 14.17 | ||
| PB Ratio | 8.03 | 5.24 | 4.85 | ||
| P/TBV Ratio | 8.06 | 5.24 | 4.85 | ||
| EV/Sales Ratio | 9.09 | 7.48 | 16.54 | ||
| Debt / Equity Ratio | 0.17 | 0.14 | 0.12 | 0.40 | 0.30 |
| Net Debt / Equity Ratio | -0.84 | -0.88 | -0.90 | -0.58 | -0.82 |
| Net Debt / EBITDA Ratio | 1.56 | 2.40 | 4.47 | 0.69 | 1.41 |
| Net Debt / FCF Ratio | 1.91 | 3.24 | 4.71 | 0.66 | 1.50 |
| Asset Turnover | 0.55 | 0.42 | 0.46 | 0.62 | |
| Inventory Turnover | 1.78 | 1.52 | 1.36 | 1.42 | |
| Quick Ratio | 8.45 | 9.08 | 15.80 | 1.97 | 7.45 |
| Current Ratio | 9.18 | 9.73 | 16.73 | 2.41 | 8.09 |
| Return on Equity (ROE) | -43.93% | -30.83% | -35.75% | -61.27% | |
| Return on Assets (ROA) | -23.38% | -17.33% | -17.46% | -25.83% | |
| Return on Capital Employed (ROCE) | -46.90% | -33.10% | -18.70% | -80.50% | -47.00% |
| Earnings Yield | -6.54% | -6.57% | -4.36% | ||
| FCF Yield | -5.42% | -5.20% | -3.95% | ||
| Buyback Yield / Dilution | -37.38% | -205.79% | -125.31% | -4.03% |